Dapar, Doraen C.

HRN: 02-28-11  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/26/2022
CEFUROXIME 500MG (TAB)
10/26/2022
11/01/2022
ORAL
500mg
BID
Thickly MSAF
Waiting Final Action 
10/26/2022
METRONIDAZOLE 500MG (TAB)
11/01/2022
10/26/2022
ORAL
500mg
Tid
Thickly Meconium AF
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: